MedPath

BAR-trial: Bioavailability of Ethanol Following Bariatric Surgery

Completed
Conditions
Obesity, Morbid
Interventions
Procedure: Gastric bypass
Procedure: gastric sleeve
Registration Number
NCT01840020
Lead Sponsor
Norwegian University of Science and Technology
Brief Summary

The first-pass metabolism (FPM) is a barrier to the toxicity of ethanol. Changes to the size and function of the stomach may alter FPM. Bariatric surgery, like the gastric bypass procedure, involves significant changes to the size and function of the stomach and leads to more rapid gastric emptying. Consequences will be faster absorption and higher peak concentration of ethanol after surgery than before. There are growing concerns that surgery for obesity in this way may cause alcohol abuse.

In this study the investigators compare changes in FPM of ethanol following two different bariatric surgical procedures.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
33
Inclusion Criteria
  • volunteers from Central Norway
  • morbid obese BMI > 40 kg/m2)
  • morbid obese BMI > 35 kg/m2 given a obesity related disease that qualifies for bariatric surgery
Exclusion Criteria
  • previous or current alcohol abuse
  • risk for alcohol harm as assessed by AUDIT
  • alcohol abstinence
  • liver disease except fatty liver, which occurs in more than 50% of those who seek bariatric surgery
  • previous colon resection
  • not/insufficiently able to informed consent
  • drugs that interact with alcohol dehydrogenase
  • drugs that slow down emptying of the stomach
  • pregnancy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Gastric bypassGastric bypasspatients recruited from Central Norway
Gastric sleevegastric sleevepatients recruited from Central Norway
Primary Outcome Measures
NameTimeMethod
Change in bioavailability of ethanolfrom baseline to 3 months, 1 year, and 3 years

bioavailability tests: Plasma concentration of ethanol. Calculation:

* Area under curve (AUC)

* Maximum concentration(Cmax)

* Time up to maximum concentration (tmax)

* Oral bioavailability (AUCpo/AUCiv)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Sykehuset Namsos

🇳🇴

Namsos, Norway

Obesity policlinic of St. Olavs Hospital

🇳🇴

Trondheim, Norway

© Copyright 2025. All Rights Reserved by MedPath